AI screening for fatty liver disease using CT scans
Part of Digestive system clinical trials.
This study uses artificial intelligence to help doctors identify fatty liver disease from CT scans you may already be having. If eligible, you'll have some blood tests and possibly an ultrasound or MRI to confirm liver health, helping catch liver disease early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having or recently had a chest or belly CT scan with good image quality
- You have recent blood work (ALT, AST, platelets) from the past month, or are willing to get these blood tests done
- You are willing to have an additional ultrasound (FibroScan) or MRI scan to check liver scarring if needed
- You do not have known liver cancer, cirrhosis, or a history of liver transplant or major liver surgery
- You are not currently pregnant or breastfeeding and do not have severe acute illness
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well primary care doctors can screen for advanced liver scarring in people with fatty liver from non-alcohol causes or from alcohol use. It may help find liver problems earlier so you can get the right follow-up.
This study uses a computer program to help doctors look for cancer in the liver on CT scans. It aims to see if the AI tool makes reading scans faster and more accurate, which could help catch issues sooner.
This study uses a computer program to look at heart ultrasound images already taken during regular care. The program finds people who might have hidden liver problems like fatty liver or liver scarring, so they can get more testing and early help.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This trial uses an AI system to help doctors plan surgery for liver cancer. It is for people who have had a CT scan of their liver and may or may not have a liver tumor.
This study uses artificial intelligence on your CT scan to help doctors make better decisions before and after liver surgery. It aims to improve safety and outcomes for people having surgery for liver cancer or other liver conditions.
Hear when a new Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.